Story thread · 2 reports / 2 sources
Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume
investors.com · 4d · first report
Halozyme stock rocketed to a record high Friday as its newer Enhanze-tied products start driving incremental growth. The post Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume appeared first on Investor's Business Daily .
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.